Advexin News
Most Popular Advexin Story
Introgen files first gene therapy for FDA approval
After 14 years of research, Introgen Therapeutics is asking the FDA to give its BLA for a gene-based therapy for head and neck cancer - Advexin -- a priority review. Experts in the field told the... Read more...
Latest Headlines
- September 2, 2008
- April 15, 2008
- September 27, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
